how big is Venky's (India)?

As of October 2023, Venkys (India) Ltd has a market capitalization of ₹2,306.03 Cr, with net sales of ₹3,306.99 Cr and a net profit of ₹116.62 Cr over the latest four quarters. Shareholder's funds are ₹1,370.24 Cr, and total assets amount to ₹2,093.75 Cr.

Market Cap: Venkys (India) Ltd has a market capitalization of 2,306.03 Cr, classifying it as a Small Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 3,306.99 Cr, and the sum of Net Profit for the same period is 116.62 Cr. This data is based on Standalone financials.<BR><BR>Balance Sheet Snapshot: This is Standalone data for the latest annual period ending March 2024. The Shareholder's Funds are reported at 1,370.24 Cr, and the Total Assets amount to 2,093.75 Cr.

When is the next results date for Venky's (India)?

No Upcoming Board Meetings

What does Venky's (India) do?

Venky's (India) Limited is an integrated poultry company in the FMCG sector, established in 1976, with a market cap of Rs 2,306 Cr and reported net sales of 843 Cr and a net profit of 13 Cr for March 2025. Key financial metrics include a P/E ratio of 20.00 and a return on equity of 7.90%.

Overview: <BR>Venky's (India) Limited is an integrated poultry group operating in the FMCG sector, categorized as a small-cap company.<BR><BR>History: <BR>The company was incorporated in July 1976 as a private limited entity and was initially known as Western Hatcheries Limited. It became a public limited company on December 12, 1998. The latest quarterly results reported net sales and profit for March 2025.<BR><BR>Financial Snapshot: <BR>Net Sales: 843 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 13 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: Rs 2,306 Cr (Small Cap)<BR><BR>Key Metrics: <BR>P/E: 20.00 <BR>Industry P/E: 54 <BR>Dividend Yield: 0.43% <BR>Debt Equity: -0.10 <BR>Return on Equity: 7.90% <BR>Price to Book: 1.55<BR><BR>Contact Details: <BR>Address: Venkateshwara House, S No 114/A/2 Pune-Sinhagad Rd Pune Maharashtra : 411030 <BR>Tel: 91-020-24251530-41 <BR>Email: corp.shares@venkys.com <BR>Website: http://www.venkys.com

Who are in the management team of Venky's (India)?

As of March 2022, the management team of Venky's (India) includes Anuradha J Desai (Chairperson), B Venkatesh Rao (Vice Chairman), B Balaji Rao (Managing Director), and several independent directors. They oversee the company's operations and strategic direction.

As of March 2022, the management team of Venky's (India) includes the following individuals:<BR><BR>1. Anuradha J Desai - Chairperson<BR>2. B Venkatesh Rao - Vice Chairman<BR>3. B Balaji Rao - Managing Director<BR>4. Jitendra M Desai - Director<BR>5. Ashok Mahajan - Independent Director<BR>6. Amit Kapur - Independent Director<BR>7. Rajeshwar Singh Rathore - Independent Director<BR>8. Rohan Ajay Bhagwat - Company Secretary & Compliance Officer<BR>9. Uttara J Desai - Director<BR>10. P Neeraja - Independent Director<BR>11. Ashutosh Nargolkar - Independent Director<BR><BR>This team is responsible for overseeing the company's operations and strategic direction.

What is the bonus history of the Venky's (India)?

Venky's (India) issued a bonus in a 1:2 ratio on December 21, 2015, granting one additional share for every two shares held, with a record date of December 22, 2015. This is the company's most recent bonus action.

Venky's (India) has a bonus history that includes a notable bonus issue announced on December 21, 2015. The company issued a bonus in the ratio of 1:2, meaning that for every two shares held, shareholders received one additional share. The record date for this bonus was December 22, 2015. This was the most recent bonus action taken by the company. If you need more details or have further questions, feel free to ask!

Has Venky's (India) declared dividend?

Yes, Venkys (India) Ltd has declared a 70% dividend, amounting to ₹7 per share, with an ex-date of August 23, 2024. While the company has declared a dividend, total returns have been negative over shorter periods, but positive over the last five years.

Venkys (India) Ltd has declared a 70% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 70%<BR>- Amount per share: 7 per share<BR>- Ex-date: 23 Aug 24<BR><BR>Dividend Yield: 0.43%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -10.77%, with a dividend return of 0%, resulting in a total return of -10.77%.<BR><BR>Over the past year, the price return was -7.84%, with a dividend return of 0.38%, leading to a total return of -7.46%.<BR><BR>In the 2-year period, the price return was -4.4%, the dividend return was 0.76%, culminating in a total return of -3.64%.<BR><BR>For the 3-year period, the price return stood at -18.25%, with a dividend return of 1.41%, resulting in a total return of -16.84%.<BR><BR>In the last 4 years, the price return was -38.71%, with a dividend return of 1.26%, leading to a total return of -37.45%.<BR><BR>Finally, over the 5-year period, the price return was 40.65%, the dividend return was 3.90%, resulting in a total return of 44.55%.<BR><BR>Overall, while Venkys (India) has declared a dividend, the total returns over various periods show a mixed performance, with negative returns in shorter periods but a positive return over the longer 5-year horizon.

Who are the peers of the Venky's (India)?

Venky's (India) peers include Hind. Unilever, ITC, Nestle India, Britannia Inds., and others, with varying management risks and growth rates. In terms of returns, Lotus Chocolate leads at 185.52%, while Venky's (India) has a 1-year return of -8.29%.

Peers: Venky's (India) has the following peers: Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, Eveready Inds., HMA Agro Inds., Andrew Yule & Co, Godavari Bioref., and Lotus Chocolate.<BR><BR>Quality Snapshot: Excellent management risk is observed at ITC, Nestle India, and Britannia Inds., while Good management risk is found at Hind. Unilever, Godrej Consumer, and Eveready Inds. Average management risk is present at Venky's (India) and HMA Agro Inds., while Below Average management risk is noted at Andrew Yule & Co and Godavari Bioref. Growth is Excellent at Lotus Chocolate, Good at Venky's (India), Average at Nestle India, and Below Average at Hind. Unilever, ITC, Britannia Inds., Godrej Consumer, Eveready Inds., HMA Agro Inds., Andrew Yule & Co, and Godavari Bioref.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Lotus Chocolate at 185.52%, while the lowest is HMA Agro Inds. at -28.09%. Venky's (India) has a 1-year return of -8.29%, which is higher than HMA Agro Inds. but lower than all other peers. Additionally, the six-month return is negative for Eveready Inds., HMA Agro Inds., and Andrew Yule & Co.

Who are the top shareholders of the Venky's (India)?

The top shareholders of Venky's (India) include Venkateshwara Hatcheries Pvt Limited with 51.61%, Tasha Enterprises LLP with 3.01%, and individual investors holding 31.14%. Additionally, 44 foreign institutional investors hold 1.39%, while mutual funds have no significant holdings.

The top shareholders of Venky's (India) include Venkateshwara Hatcheries Pvt Limited, which holds a significant 51.61% of the shares, making it the largest promoter. Other notable shareholders include Tasha Enterprises LLP, with a holding of 3.01%, and individual investors collectively holding 31.14% of the shares. Additionally, there are 44 foreign institutional investors (FIIs) that hold 1.39% of the company, while mutual funds currently do not have any significant holdings in Venky's.

Are Venky's (India) latest results good or bad?

Venky's (India) latest Q2 FY26 results are concerning, showing a net loss of ₹26.53 crores, a significant decline from previous periods, with operating margins at their lowest. Despite a slight year-on-year sales growth, the company faces serious operational challenges and investor skepticism, reflected in a 19.65% stock decline over the past year.

Venky's (India) latest results for Q2 FY26 are concerning and can be classified as bad. The company reported a net loss of ₹26.53 crores, marking a significant decline of 267.6% quarter-on-quarter and 441.9% year-on-year. This loss represents the worst operational performance in the company's recent history, with operating profit before depreciation, interest, tax, and other income (PBDIT) plunging to a negative ₹31.14 crores, a drastic drop from a positive ₹23.58 crores in the previous quarter.<BR><BR>While net sales showed a modest year-on-year growth of 3.44%, they declined by 7.50% compared to the previous quarter, indicating challenges in maintaining revenue momentum. The operating margin, excluding other income, fell to -3.89%, the lowest recorded, reflecting severe cost management issues and an inability to pass on rising input costs.<BR><BR>Overall, the financial metrics indicate significant operational distress, raising serious concerns about the sustainability of Venky's business model in the current environment. The stock has also underperformed, declining 19.65% over the past year, which further reflects investor skepticism regarding the company's near-term recovery prospects.

Is Venky's (India) overvalued or undervalued?

As of November 10, 2025, Venky's (India) is considered overvalued with a PE ratio of 83.49 and disappointing performance, reflected by a year-to-date return of -25.08%, compared to its peers like Hindustan Unilever and Nestle India.

As of 10 November 2025, Venky's (India) has moved from a fair valuation to very expensive. The company is currently overvalued, with a PE ratio of 83.49, an EV to EBITDA ratio of 13.45, and a Price to Book Value of 0.13. In comparison, Hindustan Unilever has a PE ratio of 53.51 and an EV to EBITDA of 33.13, while Nestle India shows a PE of 81.47 and an EV to EBITDA of 50.09, indicating that Venky's is trading at a premium relative to its peers.<BR><BR>The company's recent performance has been disappointing, with a year-to-date return of -25.08% compared to a positive Sensex return of 6.91%. This underperformance, combined with its high valuation metrics, reinforces the conclusion that Venky's (India) is overvalued in the current market environment.

Is Venky's (India) technically bullish or bearish?

As of November 10, 2025, Venky's (India) shows a bearish trend with strong weakness indicated by the weekly MACD, Bollinger Bands, and daily moving averages, despite a bullish monthly RSI and mild weekly KST.

As of 10 November 2025, the technical trend has changed from mildly bearish to bearish. The current technical stance for Venky's (India) is bearish with a strong indication of weakness. The weekly MACD and Bollinger Bands are both bearish, reinforcing the negative sentiment. Daily moving averages also confirm a bearish outlook. Although the monthly RSI is bullish, it does not outweigh the bearish signals from other indicators. The KST shows a mildly bullish stance on the weekly timeframe, but the overall trend remains bearish. The stock has underperformed significantly compared to the Sensex over various periods, indicating ongoing weakness.

Should I buy, sell or hold Venky's (India)?

How has been the historical performance of Venky's (India)?

Venky's (India) has seen a decline in net sales and total operating income from INR 4,233.69 crore in March 2023 to INR 3,306.99 crore in March 2025, but has improved its operating profit and profit after tax during the same period. Overall, the company faces challenges in sales while enhancing profitability metrics.

Answer:<BR>The historical performance of Venky's (India) shows a fluctuating trend in key financial metrics over the years.<BR><BR>Breakdown:<BR>Venky's (India) has experienced a decline in net sales from INR 4,233.69 crore in March 2023 to INR 3,306.99 crore in March 2025. This decline is mirrored in total operating income, which also decreased from INR 4,233.69 crore in March 2023 to INR 3,306.99 crore in March 2025. The raw material cost has similarly decreased from INR 3,281.73 crore in March 2023 to INR 2,184.96 crore in March 2025. Operating profit (PBDIT) has shown some recovery, increasing from INR 149.24 crore in March 2023 to INR 215.78 crore in March 2025, while profit after tax rose from INR 70.48 crore in March 2023 to INR 116.62 crore in March 2025. The company's total liabilities decreased slightly from INR 2,093.75 crore in March 2024 to INR 2,070.34 crore in March 2025, while total assets also saw a decrease from INR 2,093.75 crore to INR 2,070.34 crore in the same period. Cash flow from operating activities has declined from INR 86 crore in March 2023 to INR 66 crore in March 2025, indicating a tightening cash position. Overall, while Venky's has faced challenges in sales and total income, it has managed to improve its profitability metrics in recent years.

Which are the latest news on Venky's (India)?

Why is Venky's (India) falling/rising?

As of 03-Dec, Venkys (India) Ltd's stock price is 1,348.50, reflecting a slight decline and a broader trend of underperformance against benchmark indices. Poor financial results, low operational efficiency, and declining investor confidence contribute to the stock's downward trajectory.

As of 03-Dec, Venkys (India) Ltd's stock price is currently at 1,348.50, reflecting a slight decline of 0.1 (-0.01%). The stock has been experiencing a downward trend, having fallen consecutively for the last two days, resulting in a total decline of -0.63% during this period. This recent performance is part of a broader trend, as the stock has underperformed significantly against the benchmark indices over various time frames, including a -23.10% return over the past year compared to a +5.27% return for the Sensex.<BR><BR>The company's financial health appears to be a contributing factor to its falling stock price. Recent negative results, including a PAT of Rs -26.53 crore, indicate a substantial decline of -285.3% compared to the previous four-quarter average. Additionally, the company's return on capital employed (ROCE) is at a low of 3.38%, and its inventory turnover ratio is the lowest at 12.78 times. These metrics suggest poor operational efficiency and profitability, which may deter investors.<BR><BR>Moreover, the stock is trading at a premium relative to its peers, with a Price to Book Value of 1.3, indicating a potentially overvalued position in the market. The lack of confidence from domestic mutual funds, which hold only 0.01% of the company, further underscores concerns about the stock's valuation and future growth prospects. <BR><BR>Overall, the combination of poor financial performance, consistent underperformance against benchmarks, and declining investor participation, as evidenced by a 37.75% drop in delivery volume, contributes to the stock's current downward trajectory.